MicroMed raises $23 million:
This article was originally published in Clinica
Executive Summary
MicroMed Technology has raised $23m in a private placement to new and existing investors. The proceeds will fund the European commercialisation of the Houston, Texas company's main product, the DeBakey ventricular assist device (VAD), which has received CE mark approval. It will also be spent on US clinical trials of the product as a bridge to heart transplant and for patients for whom a heart transplant is contra-indicated. The company says it will also close a $5m bank line of credit soon.